FDA
Advertisement
Furosemide (Furoscix) has been approved by the FDA for the treatment of edema in patients with chronic kidney disease (CKD).
Travere will submit an application to the FDA requesting approval of sparsentan for focal segmental glomerulosclerosis.
The FDA recalled a batch of Dr. Reddy’s Cinacalcet Tablets, a treatment for chronic kidney disease (CKD).
The FDA removed two dialysis-related product codes from its device shortage list.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.